BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86%
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

Intrinsic Value

The intrinsic value of one BNN stock under the Base Case scenario is 5.17 EUR. Compared to the current market price of 3.44 EUR, BRAIN Biotech AG is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BNN Intrinsic Value
5.17 EUR
Undervaluation 33%
Intrinsic Value
Price
Base Case Scenario

Valuation History
BRAIN Biotech AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BNN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BNN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about BNN?
Bearish
Neutral
Bullish

Fundamental Analysis

3.44 EUR
-0.86%
-0.86%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

BRAIN Biotech AG
DE
Chemicals
Market Cap
75.2m EUR
IPO
Feb 9, 2016
Employees
293
Germany
Market Cap
75.2m EUR
Industry
Chemicals
IPO
Feb 9, 2016
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about BRAIN Biotech AG

Provide an overview of the primary business activities
of BRAIN Biotech AG.

What unique competitive advantages
does BRAIN Biotech AG hold over its rivals?

What risks and challenges
does BRAIN Biotech AG face in the near future?

Has there been any significant insider trading activity
in BRAIN Biotech AG recently?

Summarize the latest earnings call
of BRAIN Biotech AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for BRAIN Biotech AG.

Provide P/S
for BRAIN Biotech AG.

Provide P/E
for BRAIN Biotech AG.

Provide P/OCF
for BRAIN Biotech AG.

Provide P/FCFE
for BRAIN Biotech AG.

Provide P/B
for BRAIN Biotech AG.

Provide EV/S
for BRAIN Biotech AG.

Provide EV/GP
for BRAIN Biotech AG.

Provide EV/EBITDA
for BRAIN Biotech AG.

Provide EV/EBIT
for BRAIN Biotech AG.

Provide EV/OCF
for BRAIN Biotech AG.

Provide EV/FCFF
for BRAIN Biotech AG.

Provide EV/IC
for BRAIN Biotech AG.

Show me price targets
for BRAIN Biotech AG made by professional analysts.

What are the Revenue projections
for BRAIN Biotech AG?

How accurate were the past Revenue estimates
for BRAIN Biotech AG?

What are the Net Income projections
for BRAIN Biotech AG?

How accurate were the past Net Income estimates
for BRAIN Biotech AG?

What are the EPS projections
for BRAIN Biotech AG?

How accurate were the past EPS estimates
for BRAIN Biotech AG?

What are the EBIT projections
for BRAIN Biotech AG?

How accurate were the past EBIT estimates
for BRAIN Biotech AG?

Compare the revenue forecasts
for BRAIN Biotech AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of BRAIN Biotech AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of BRAIN Biotech AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of BRAIN Biotech AG compared to its peers.

Compare the P/E ratios
of BRAIN Biotech AG against its peers.

Discuss the investment returns and shareholder value creation
comparing BRAIN Biotech AG with its peers.

Analyze the financial leverage
of BRAIN Biotech AG compared to its main competitors.

Show all profitability ratios
for BRAIN Biotech AG.

Provide ROE
for BRAIN Biotech AG.

Provide ROA
for BRAIN Biotech AG.

Provide ROIC
for BRAIN Biotech AG.

Provide ROCE
for BRAIN Biotech AG.

Provide Gross Margin
for BRAIN Biotech AG.

Provide Operating Margin
for BRAIN Biotech AG.

Provide Net Margin
for BRAIN Biotech AG.

Provide FCF Margin
for BRAIN Biotech AG.

Show all solvency ratios
for BRAIN Biotech AG.

Provide D/E Ratio
for BRAIN Biotech AG.

Provide D/A Ratio
for BRAIN Biotech AG.

Provide Interest Coverage Ratio
for BRAIN Biotech AG.

Provide Altman Z-Score Ratio
for BRAIN Biotech AG.

Provide Quick Ratio
for BRAIN Biotech AG.

Provide Current Ratio
for BRAIN Biotech AG.

Provide Cash Ratio
for BRAIN Biotech AG.

What is the historical Revenue growth
over the last 5 years for BRAIN Biotech AG?

What is the historical Net Income growth
over the last 5 years for BRAIN Biotech AG?

What is the current Free Cash Flow
of BRAIN Biotech AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for BRAIN Biotech AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BRAIN Biotech AG

Current Assets 29.3m
Cash & Short-Term Investments 10.4m
Receivables 8.8m
Other Current Assets 10.1m
Non-Current Assets 43.9m
Long-Term Investments 1.1m
PP&E 28.2m
Intangibles 14.6m
Other Non-Current Assets 78k
Current Liabilities 14.6m
Accounts Payable 4.5m
Other Current Liabilities 10.1m
Non-Current Liabilities 40.3m
Long-Term Debt 4.3m
Other Non-Current Liabilities 36m
Efficiency

Earnings Waterfall
BRAIN Biotech AG

Revenue
56.3m EUR
Cost of Revenue
-24.4m EUR
Gross Profit
31.9m EUR
Operating Expenses
-37.7m EUR
Operating Income
-5.8m EUR
Other Expenses
-3m EUR
Net Income
-8.8m EUR

Free Cash Flow Analysis
BRAIN Biotech AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BNN Profitability Score
Profitability Due Diligence

BRAIN Biotech AG's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
28/100
Profitability
Score

BRAIN Biotech AG's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

BNN Solvency Score
Solvency Due Diligence

BRAIN Biotech AG's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
41/100
Solvency
Score

BRAIN Biotech AG's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BNN Price Targets Summary
BRAIN Biotech AG

Wall Street analysts forecast BNN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNN is 7.23 EUR with a low forecast of 5.25 EUR and a high forecast of 10.5 EUR.

Lowest
Price Target
5.25 EUR
53% Upside
Average
Price Target
7.23 EUR
110% Upside
Highest
Price Target
10.5 EUR
205% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BNN?

Click here to dive deeper.

Dividends

BRAIN Biotech AG
does not pay dividends
Shareholder Yield

Current shareholder yield for BNN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BNN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one BNN stock?

The intrinsic value of one BNN stock under the Base Case scenario is 5.17 EUR.

Is BNN stock undervalued or overvalued?

Compared to the current market price of 3.44 EUR, BRAIN Biotech AG is Undervalued by 33%.

Back to Top